[Viferon efficacy in influenza in adult patients].

Abstract

The therapeutic efficacy of Viferon (suppositories of human recombinant interferon alfa-2) was investigated in a double-blind controlled study with the use of Arbidol as a reference drug in the treatment of patients with influenza. Viferon and Arbidol lowered the signs of the fever, intoxication, catarrh and the disease as the whole.

• Authors: A N Vasil'ev, R Z Gatich, L V Kolobukhina, E I Isaeva, E I Burtseva, T G Orlova, F V Voronina, V V Malinovskaia
• Journal: Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] (Antibiot Khimioter) Vol. 54 Issue 3-4 Pg. 21-5 ( 2009) ISSN: 0235-2990 [Print] Russia (Federation)
• PMID: 19711845 (Publication Type: Journal Article, Randomized Controlled Trial)

Chemical References

• Antiviral Agents
• Indoles
• Interferon alpha-2
• Interferon-alpha
• Recombinant Proteins
• Suppositories
• umifenovir

Topics

• Adolescent
• Adult
• Antiviral Agents (adverse effects, therapeutic use)
• Double-Blind Method
• Female
• Humans
• Indoles (adverse effects, therapeutic use)
• Influenza, Human (drug therapy)
• Interferon alpha-2
• Interferon-alpha (adverse effects, therapeutic use)
• Male
• Middle Aged
• Recombinant Proteins
• Suppositories
• Treatment Outcome